Showing results (281-290 of 457) with videos related to

Sort By:
Pageof 46
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancerJ Bellmunt, B J Eigl, E Senkus, et al.
World Journal of Urology|September 22, 2018
SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancerAxel S Merseburger, Andrea B Apolo, Simon Chowdhury, et al.
Future Oncology (London, England)|January 29, 2019
Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationaleViktor Grünwald, Thomas Powles, Toni K Choueiri, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2013
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety updateCora N Sternberg, Robert E Hawkins, John Wagstaff, et al.
Prostate Cancer and Prostatic Diseases|January 25, 2017
Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAILA H Bryce, J J Alumkal, A Armstrong, et al.
Anticancer Research|January 31, 2025
Mesonephric Adenocarcinoma in a Young Male PatientDaniela Guevara, Nara Shin, Alexandra Boiko, et al.
Anticancer Research|January 31, 2025
Unusual Presentation of Advanced Urothelial Cancer in a Young PatientDaniela Guevara, Nara Shin, Alexandra Boiko, et al.
Cold Spring Harbor Molecular Case Studies|April 28, 2022
Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumabHussein Alnajar, Hiranmayi Ravichandran, André Figueiredo Rendeiro, et al.
BMC Cancer|July 25, 2024
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 studyIrfan Cicin, Elizabeth R Plimack, Howard Gurney, et al.
BMC Cancer|August 23, 2023
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)Ariel E Marciscano, Sydney Wolfe, Xi Kathy Zhou, et al.
Pageof 46